ISSN: 0008-543X

Cancer Q1 Unclaimed

John Wiley & Sons Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer is a journal indexed in SJR in Oncology and Cancer Research with an H index of 327. Journal with a Single blind Peer Review review system, and It has a price of 2500 €. The scope of the journal is focused on Cancer, Medicine, Oncology, Cancer statistics, Cancer Diagnosis. It has an SJR impact factor of 2,736 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,736.

Cancer focuses its scope in these topics and keywords: cancer, patients, cell, squamous, carcinoma, breast, care, human, study, prostate, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q1) Oncology (Q1)

Price

2500 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

2,736

SJR Impact factor

327

H Index

559

Total Docs (Last Year)

1879

Total Docs (3 years)

16694

Total Refs

9376

Total Cites (3 years)

1346

Citable Docs (3 years)

4.79

Cites/Doc (2 years)

29.86

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

CA - A Cancer Journal for Clinicians Q1
Molecular Cancer Q1
JAMA oncology Q1
Cancer Discovery Q1
Journal of Hematology and Oncology Q1

Compare this journals

Aims and Scope

Best articles by citations

Locally advanced breast cancer

Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomy

RefractoryAspergillus pneumonia in patients with acute leukemia

Scoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma

Oncofertility and preservation of reproductive capacity in children and young adults

Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma - Identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group

Increasing the pool of academically oriented African-American medical and surgical oncologists

Cell-mediated immunity to varicella zoster virus in children being treated for cancer

Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha

Changes in standardized mortality rates from thyroid cancer in Korea between 1985 and 2015: Analysis of Korean national data

Adenosquamous carcinoma of the pancreas

Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies

SHOW MORE ARTICLES

Detection, treatment, and outcome of isolated supraclavicular recurrence in 42 patients with invasive breast carcinoma

Message from the editor

Fine-needle cytology and flow cytometry immunophenotyping and subclassification of non-hodgkin lymphoma

Intensity of immunosuppressive therapy and the incidence of pneumocystis carinii pneumonitis

Hospitalization of an oncology patient suspected of having severe acute respiratory syndrome

The value of routine follow-up in patients treated for carcinoma of the vulva

FDG-PET after 1 cycle of therapy predicts outcome in diffuse large cell lymphoma and classic Hodgkin disease

Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: A report from the Children's Oncology Group

Advance directives in the intensive care unit of a tertiary cancer center

Touch imprint cytology of axillary lymph nodes after neoadjuvant chemotherapy in patients with breast carcinoma

Author reply

Mycotic infections in leukemic patients at autopsy